HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagonists.

Abstract
A series of novel group I metabotropic glutamate receptor (mGlu) antagonists have been designed on the basis of the 4-carboxyphenylglycine pharmacophore. The compounds are either mGlu1 receptor selective or equipotent for both mGlu1 and mGlu5 receptors and have IC(50) values ranging from 1 to 30 microM determined by phosphoinositide hydrolysis (PI) assay in vitro. All the compounds produced dose-dependent inhibition of group I mGlu receptor agonist (RS)-3,5-dihydroxyphenylglycine (DHPG)-induced limbic seizure responses in mice with ED(50) values ranging from 9 nmol for LY393053 to 138 nmol for LY339840 after intracerebroventricular injection and were more potent than the mGlu1 receptor antagonist 1-aminoindan-1,5-dicarboxylic acid (ED(50)=477 nmol). Further antagonist actions were also demonstrated in a model of (RS)-DHPG-induced PI hydrolysis in vivo such that LY367385 and the active cis isomer of LY393053 produced dose-dependent inhibition of PI responses in both cerebellum and hippocampus. Cis LY393053 also inhibited hippocampal PI responses when administered intraperitoneally at a dose of 30 mg/kg. These compounds define a new series of group I mGlu receptor antagonists which may serve as useful experimental tools.
AuthorsAnn E Kingston, Kelly Griffey, Michael P Johnson, Mary-Jo Chamberlain, Gerald Kelly, Rosemarie Tomlinson, Rebecca A Wright, Bryan G Johnson, Darryle D Schoepp, John R Harris, Barry P Clark, Richard S Baker, Joseph T Tizzano
JournalNeuroscience letters (Neurosci Lett) Vol. 330 Issue 2 Pg. 127-30 (Sep 20 2002) ISSN: 0304-3940 [Print] Ireland
PMID12231428 (Publication Type: Journal Article)
Chemical References
  • 2-amino-2-(3-carboxycyclobutyl)-3-(9H-xanthen-9-yl)propionic acid
  • 2-amino-2-(4-carboxyphenyl)-3-(9H-xanthen-9-yl)propanoic acid
  • 2-methyl-3-hydroxy-4-carboxyphenylglycine
  • Benzoates
  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Antagonists
  • LY393053
  • Propionates
  • Receptors, Metabotropic Glutamate
  • Resorcinols
  • Thiophenes
  • Xanthenes
  • alpha-thioxantylmethyl-4-carboxyphenylglycine
  • carboxyphenylglycine
  • metabotropic glutamate receptor type 1
  • alpha-methyl-4-carboxyphenylglycine
  • 3,5-dihydroxyphenylglycine
  • Alanine
  • Glycine
Topics
  • Alanine (analogs & derivatives, pharmacology)
  • Animals
  • Benzoates (pharmacology)
  • Cerebellum (drug effects, metabolism)
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Excitatory Amino Acid Agonists (pharmacology)
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Glycine (analogs & derivatives, chemistry, pharmacology)
  • Hippocampus (drug effects, metabolism)
  • Inhibitory Concentration 50
  • Mice
  • Propionates (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Metabotropic Glutamate (agonists, antagonists & inhibitors, metabolism)
  • Resorcinols (pharmacology)
  • Seizures (prevention & control)
  • Structure-Activity Relationship
  • Thiophenes (pharmacology)
  • Xanthenes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: